CS
IHE icon

Credit Suisse’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Credit Suisse’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-116,532
Closed -$6.07M – 4091
2017
Q3 		$6.07M Hold
116,532
– – 0.01% 1619
2017
Q2 		$6.03M Buy
116,532
+29,283
+34% +$1.48M 0.01% 1516
2017
Q1 		$4.39M Buy
87,249
+81,381
+1,387% +$4.03M ﹤0.01% 1751
2016
Q4 		$277K Sell
5,868
-89,997
-94% -$4.27M ﹤0.01% 3693
2016
Q3 		$4.78M Buy
95,865
+48,279
+101% +$2.45M ﹤0.01% 1693
2016
Q2 		$2.29M Sell
47,586
-28,029
-37% -$1.33M ﹤0.01% 2234
2016
Q1 		$3.45M Buy
75,615
+67,647
+849% +$3.17M ﹤0.01% 1787
2015
Q4 		$429K Sell
7,968
-750
-9% -$39.5K ﹤0.01% 3491
2015
Q3 		$430K Sell
8,718
-39,840
-82% -$2.28M ﹤0.01% 3500
2015
Q2 		$2.83M Sell
48,558
-24,861
-34% -$1.45M ﹤0.01% 2262
2015
Q1 		$4.22M Buy
73,419
+37,050
+102% +$2.03M ﹤0.01% 1805
2014
Q4 		$1.83M Buy
36,369
+480
+1% +$23.4K ﹤0.01% 2606
2014
Q3 		$1.68M Hold
35,889
– – ﹤0.01% 2631
2014
Q2 		$1.62M Buy
35,889
+28,845
+409% +$1.24M ﹤0.01% 2897
2014
Q1 		$297K Sell
7,044
-360
-5% -$15.1K ﹤0.01% 4115
2013
Q4 		$291K Buy
7,404
+180
+2% +$6.75K ﹤0.01% 4093
2013
Q3 		$256K Sell
7,224
-120
-2% -$4.22K ﹤0.01% 3866
2013
Q2 		$244K Buy
+7,344
New +$244K ﹤0.01% 3756

Other funds holding IHE

CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Credit Suisse's IHE Position: Q4 2017 in Review

Credit Suisse sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2017, closing a stake of 116,532 shares — an estimated $6.07M sold.

Credit Suisse first reported a position in IHE in Q2 2013 and held it in 18 quarters. The position peaked at $6.07M in Q3 2017. 108 funds tracked by Wall St. Rank hold IHE as of Q4 2017.

  • Credit Suisse reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2017 after selling out during the quarter.
  • Credit Suisse sold 116,532 iShares US Pharmaceuticals ETF shares in Q4 2017, an estimated $6.07M.
  • Credit Suisse first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 18 quarters.
  • Credit Suisse's iShares US Pharmaceuticals ETF position peaked at $6.07M in Q3 2017.
  • 108 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2017.

Based on Credit Suisse's 13F filing for Q4 2017, filed 14 Feb 2018.